[1]
Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D. Hypertension prevalence and control among adults: United States, 2015-2016. NCHS Data Brief 2017; 289: 1-8.
[2]
Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control. Circulation 2016; 134(6): 441-50.
[3]
Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012; 380(9859): 2224-60.
[4]
Baillie I. Insight: Non-destructive testing and condition monitoring. Bindt 2018; 60(2): 62.
[5]
Murray CJL, Lopez AD. Measuring the global burden of disease. N Engl J Med 2013; 369(5): 448-57.
[6]
Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115mmHg, 1990-2015. JAMA 2017; 317(2): 165-82.
[7]
Sheeran P, Gollwitzer PM, Bargh JA. Nonconscious processes and health. Health Psychol 2013; 32(5): 460-73.
[8]
Ninomiya T, Ohara T, Hirakawa Y, et al. Midlife and late-life blood pressure and dementia in japanese elderly: The hisayama study. Hypertension 2011; 58(1): 22-8.
[9]
Wysocki M, Luo X, Schmeidler J, et al. Hypertension is associated with cognitive decline in elderly people at high risk for dementia. Am J Geriatr Psychiatry 2012; 20(2): 179-87.
[10]
Tel H. Anger and depression among the elderly people with hypertension. Neurol Psychiatry Brain Res 2013; 19(3): 109-13.
[11]
Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation 2011; 123(8): 933-44.
[12]
Sarki AM, Nduka CU, Stranges S, Kandala NB, Uthman OA. Prevalence of hypertension in low- and middle-income countries: A systematic review and meta-analysis. Medicine (United States) 2015; 94(50): e1959.
[13]
Ma YQ, Mei WH, Yin P, Yang XH, Rastegar SK, Yan JD. Prevalence of hypertension in Chinese cities: A meta-analysis of published studies. PLoS One 2013; 8(3): e58302.
[14]
Haghdoost AA, Sadeghirad B, Rezazadehkermani M. Epidemiology and heterogeneity of hypertension in Iran: A systematic review. Arch Iran Med 2008; 1: 444-52.
[15]
Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980-2012: A systematic review. J Tehran Univ Heart Cent 2016; 11(4): 159-67.
[16]
Basiratnia M, Derakhshan D, Ajdari S, Saki F. Prevalence of childhood obesity and hypertension in south of Iran. Iran J Kidney Dis 2013; 1: 282-9.
[17]
Rafraf M, Pourghassem Gargari B, Safaiyan A. Prevalence of prehypertension and hypertension among adolescent high school girls in Tabriz, Iran. Food Nutr Bull 2010; 31(3): 461-5.
[18]
Yazdanpanah L, Shahbazian H, Shahbazian H, Latifi S-M. Prevalence, awareness and risk factors of hypertension in southwest of Iran. J Renal Inj Prev 2015; 4(2): 51-6.
[19]
Ma WJ, Tang JL, Zhang YH, et al. Hypertension prevalence, awareness, treatment, control, and associated factors in adults in Southern China. Am J Hypertens 2012; 25(5): 590-6.
[20]
Fezeu L, Kengne AP, Balkau B, Awah PK, Mbanya JC. Ten-year change in blood pressure levels and prevalence of hypertension in urban and rural Cameroon. J Epidemiol Community Health 2010; 64(4): 360-5.
[21]
Lloyd-Jones D, Adams R, Carnethon M, et al. Epidemiology of hypertension. In: Hypertension: A Companion to Braunwald’s Heart Disease. Second Edition. Elsevier Inc. 2012; p. 488.
[22]
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42(6): 1206-52.
[23]
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol 2009; 62(10): e1-e34.
[24]
Ghanei Gheshlagh R, Nazari M, Baghi V, Dalvand S, Dalvandi A, Sayehmiri K. Underreporting of needlestick injuries among healthcare providers in iran: A systematic review and meta-analysis. Hayat 2017; 23(3): 201-13.
[25]
Ghanei Gheshlagh R, Sayehmiri K, Ebadi A, Dalvandi A, Dalvand S, Nourozi Tabrizi K. Resilience of patients with chronic physical diseases: A systematic review and meta-analysis. Iran Red Crescent Med J 2016; 18(7): e38562.
[26]
Tsimicalis A, Stinson J, Stevens B. Quality of life of children following bone marrow transplantation: Critical review of the research literature. Eur J Oncol Nurs 2005; 9(3): 218-38.
[27]
Hoodin F, Weber S. A systematic review of psychosocial factors affecting survival after bone marrow transplantation. Psychosomatics 2003; 44(3): 181-95.
[28]
Akbarzadeh M, Moradi F, Dabbaghmaneh MH, Jafari P, Parsaneshad MA. A survey of hypertension and hyperandrogenemia in the first degree relatives of women with polycystic ovarian syndrome referring to gynecology clinics of Shiraz Medical University. Pars J Med Sci 2011; 9(2): 26-32.
[29]
Faramarzi H, Bagheri P, Bahrampour A, Halimi L, Rahimi N, Ebrahimi M. The comparison of prevalence of diabete and hypertension between rural areas of fars and rural area of EMRO region. Indian J Endocrinol Metab 2011; 13(2): 157-64.
[30]
Wilkins E, Wilson L, Wickramasinghe K, et al. European
cardiovascular disease statistics 2017. 2017; European Heart
Network, Publisher. AISBL, Rue Montoyer 31, B-1000 Brussels,
Belgium.
[31]
Mahram M, Shahsavari D, Oveisi S, Jalilolghadr S. Comparison of hypertension and diabetes mellitus prevalence in areas with and without water arsenic contamination. J Res Med Sci 2013; 18(5): 408-12.
[32]
Mojahedi MJ, Hami M, Shakeri MT, Mohammad Hossein Hassani MA. Prevalence of high blood pressure in young people and its related risk factors in Mashhad. Med J Mashhad Univ Med Sci 2015; 58(2): 252-7.
[33]
Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009; 27(5): 963-75.
[34]
Yang J, Lu F, Zhang C, et al. Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res 2010; 33(4): 331-7.
[35]
Sun Z. Aging, arterial stiffness, and hypertension. Hypertension 2015; 65(2): 252-6.
[36]
Taraghi Z, Hali E. Hypertension screening in truck drivers. Hayat 2004; 10(21): 95.
[37]
Addo J, Smeeth L, Leon DA. Hypertension in sub-Saharan Africa: A systematic review. Hypertension 2007; 50(6): 1012-8.
[38]
Cooper RS, Amoah AGB, Mensah GA. High blood pressure: The foundation for epidemic cardiovascular disease in African populations. Ethn Dis 2003; 13(2)(Suppl. 2): S2-S52.
[39]
Bello M. Nigerians wake up to high blood pressure. Bull World Health Organ 2013; 91(4): 242-3.
[40]
Delavari AR, Horri N, Alikhani S, et al. Prevalence of hypertension in Iranian urban and rural populations aged over 20 years in 2004. J Mazandaran Univ Med Sci 2007; 17(58): 79-86.
[41]
Efstratopoulos AD, Voyaki SM, Baltas AA, et al. Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: The hypertension study in general practice in Hellas (HYPERTENSHELL) national study. Am J Hypertens 2006; 19(1): 53-60.
[42]
Van de Poel E, O’Donnell O, Van Doorslaer E. Urbanization and the spread of diseases of affluence in China. Econ Hum Biol 2009; 7(2): 200-16.
[43]
Adeloye D, Basquill C, Aderemi AV, Thompson JY, Obi FA. An estimate of the prevalence of hypertension in Nigeria: A systematic review and meta-analysis. J Hypertens 2015; 33(2): 230-42.
[44]
Mezue K. The increasing burden of hypertension in Nigeria - Can a dietary salt reduction strategy change the trend? Perspect Public Health 2014; 134(6): 346-52.
[45]
Mainous AG, King DE, Garr DR, Pearson WS. Race, rural residence, and control of diabetes and hypertension. Annals Family Med 2004; 2(6): 563-8.
36
5